Thoracoscopic Pleural Biopsy in Sohag University Hospital

Launched by SOHAG UNIVERSITY · Apr 30, 2025

Keywords

ClinConnect Summary

This clinical trial at Sohag University Hospital is studying a procedure called thoracoscopic pleural biopsy, which helps doctors diagnose diseases affecting the pleura, the thin membrane surrounding the lungs. The goal is to understand how effective and safe this procedure is, as well as how it can improve patient outcomes. The trial is currently looking for participants who are adults aged 18 and older, have symptoms suggesting a pleural disease, and have already had necessary tests like chest X-rays or CT scans that indicate they might need a biopsy.

If you or a family member are considering participating, it’s important to know that not everyone will be eligible. For example, individuals who have conditions that make the biopsy unsafe or those who are currently pregnant cannot participate. During the study, participants will undergo the biopsy procedure, and doctors will closely monitor their health and recovery. This trial aims to gather valuable information that could lead to better diagnosis and treatment options for pleural diseases in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy
• • Age: Adults aged 18 years and older
• • Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy.
• Exclusion Criteria:
• • Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy
• • Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy).
• • Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation.
• • Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations.
• • Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons.
• • Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.